Clicky

Agenus Inc.(AGEN) News

Date Title
Mar 24 3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
Mar 17 US$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results
Mar 15 Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript
Mar 15 Analysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramatically
Mar 14 Agenus (AGEN) Q4 2023 Earnings Call Transcript
Mar 14 Agenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipeline
Mar 14 Agenus Reports Fourth Quarter and Full Year 2023 Results
Mar 6 Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
Mar 5 Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 29 Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
Feb 26 Agenus to Participate in Leerink Partners Global Biopharma Conference
Jan 22 Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
Jan 16 Institutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses
Dec 26 Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag
Dec 24 2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
Dec 21 GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
Dec 20 Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
Dec 13 Blueprint (BPMC) Gets EC Nod for Ayvakit Expanded Use, Stock Up
Dec 11 Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
Dec 7 Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study